Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 4 | 1 |
| List of Figures | 4 | 1 |
| Introduction | 5 | 1 |
| Global Markets Direct Report Coverage | 5 | 1 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Overview | 6 | 1 |
| Therapeutics Development | 7 | 3 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Products under Development by Stage of Development | 7 | 1 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Products under Development by Therapy Area | 8 | 1 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Products under Development by Indication | 9 | 1 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Pipeline Products Glance | 10 | 2 |
| Late Stage Products | 10 | 1 |
| Early Stage Products | 11 | 1 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Products under Development by Companies | 12 | 2 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Products under Development by Universities/Institutes | 14 | 2 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Therapeutics Assessment | 16 | 5 |
| Assessment by Monotherapy/Combination Products | 16 | 1 |
| Assessment by Mechanism of Action | 17 | 1 |
| Assessment by Route of Administration | 18 | 1 |
| Assessment by Molecule Type | 19 | 2 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Companies Involved in Therapeutics Development | 21 | 1 |
| Integrated BioTherapeutics, Inc. | 21 | 1 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Drug Profiles | 22 | 9 |
| CIGB-230 Drug Profile | 22 | 1 |
| E-137 Drug Profile | 23 | 1 |
| E-20 Drug Profile | 24 | 1 |
| hepatitis C (strain H77) vaccine Drug Profile | 25 | 1 |
| MBL-HCV-1 Drug Profile | 26 | 1 |
| Monoclonal Antibodies to Inhibit E2 Glycoprotein for HCV Drug Profile | 27 | 1 |
| Monoclonal Antibodies to Inhibit Viral E1/E2 Proteins for Hepatitis C Drug Profile | 28 | 1 |
| Monoclonal Antibody to Inhibit E1 and E2 Glycoprotein for Hepatitis C Drug Profile | 29 | 1 |
| Monoclonal Antibody to Target E2 for Hepatitis C Drug Profile | 30 | 1 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Dormant Projects | 31 | 1 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Discontinued Products | 32 | 1 |
| Hepatitis C Virus (HCV) Envelope Protein E2 Featured News &Press Releases | 33 | 2 |
| Jun 10, 2013: IBT and Stanford Awarded STTR | 33 | 1 |
| Aug 30, 2012: Researchers Develop Monoclonal Antibody That Prevents Hepatitis C In Animal Model | 33 | 2 |
| Appendix | 35 | 2 |
| Methodology | 35 | 1 |
| Coverage | 35 | 1 |
| Secondary Research | 35 | 1 |
| Primary Research | 35 | 1 |
| Expert Panel Validation | 35 | 1 |
| Contact Us | 35 | 1 |
| Disclaimer | 36 | 1 |